Portfolio company
Neobiomics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops and provides clinical nutritional products, including probiotic blends and fatty acid oils, for preterm infants in neonatal intensive care units.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Astarte Medical
This clinical intelligence company develops software and predictive analytics to standardise feeding and optimise nutrition for preterm infants in neonatal intensive care units.
BoobyBiome
This biotechnology company develops microbiome-preserving storage accessories and bacterial supplements for infants to support gut and immune system development.
Astarte
This company provides clinical decision support software to hospital neonatal intensive care units for monitoring and standardising nutrition and feeding protocols for preterm infants.
Tellus Therapeutics
This company develops biopharmaceutical treatments for white matter brain injury in premature infants to improve neurodevelopmental outcomes.
Cimon Medical
This company develops Doppler ultrasound technology for continuous blood flow monitoring in premature and critically ill infants within healthcare facilities.
Kangaroo Bio
This company develops artificial womb technology for neonatal care providers and therapeutic researchers to support fetal development outside the body.
SIME Clinical AI
This company develops an AI platform and point-of-care devices for rapid respiratory disease prediction and diagnostics in neonatal and adult intensive care units.
ENHANCED MEDICAL NUTRITION
This company develops medical food products and surgical nutrition programmes for patients preparing for and recovering from surgery and critical illness.
